How has been the historical performance of Satin Creditcare?
Satin Creditcare has shown growth in net sales and operating income, increasing from 1,376.80 Cr in Mar'22 to 2,594.69 Cr in Mar'25. However, profitability has declined, with profit before tax dropping from 582.89 Cr in Mar'24 to 235.77 Cr in Mar'25, alongside rising total liabilities and negative cash flow from operating activities.
Answer:The historical performance of Satin Creditcare shows significant fluctuations in key financial metrics over the years.Breakdown:
Satin Creditcare's net sales have shown a steady increase, rising from 1,376.80 Cr in Mar'22 to 2,594.69 Cr in Mar'25. The total operating income followed a similar trend, reaching 2,594.69 Cr in Mar'25, up from 1,376.80 Cr in Mar'22. However, the total expenditure, excluding depreciation, also increased significantly, from 705.07 Cr in Mar'22 to 1,290.26 Cr in Mar'25. Operating profit (PBDIT) peaked at 1,311.65 Cr in Mar'25, although it was lower than the previous year's 1,506.57 Cr. The profit before tax saw a decline from 582.89 Cr in Mar'24 to 235.77 Cr in Mar'25, while the profit after tax dropped from 435.94 Cr to 186.13 Cr in the same period. The company's total liabilities increased from 10,475.62 Cr in Mar'24 to 11,542.59 Cr in Mar'25, with total debt also rising from 7,909.64 Cr to 8,791.44 Cr. Cash flow from operating activities remained negative, at -563.00 Cr in Mar'25, although the net cash inflow improved to 305.00 Cr from 166.00 Cr in Mar'24. Overall, while Satin Creditcare has experienced growth in sales and operating income, it faces challenges with profitability and increasing liabilities.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
